Reactive oxidative and nitrogen species in the nigrostriatal system following striatal 6-hydroxydopamine lesion in rats
暂无分享,去创建一个
Andreas Hartmann | Wolfgang H. Oertel | W. Oertel | A. Hartmann | Carmen Henze | Christopher Earl | Jürgen Sautter | Nicole Schmidt | Claudia Themann | J. Sautter | C. Earl | N. Schmidt | C. Henze | C. Themann
[1] B. Ferger,et al. Comparison of two independent aromatic hydroxylation assays in combination with intracerebral microdialysis to determine hydroxyl free radicals , 2001, Journal of Neuroscience Methods.
[2] U. Ungerstedt,et al. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. , 1968, European journal of pharmacology.
[3] A. Favier,et al. High-performance liquid chromatography-electrochemical determination of salicylate hydroxylation products as an in vivo marker of oxidative stress. , 1995, Analytical biochemistry.
[4] C. Marsden,et al. A Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia Nigra , 1989, Journal of neurochemistry.
[5] J. Zweier,et al. Detection of hydroxyl radicals by D-phenylalanine hydroxylation: a specific assay for hydroxyl radical generation in biological systems. , 2001, Analytical biochemistry.
[6] G. Paxinos,et al. The Rat Brain in Stereotaxic Coordinates , 1983 .
[7] H. Thoenen,et al. 6-Hydroxydopamine and catecholamine neurons , 1971 .
[8] R. Marttila,et al. Oxygen toxicity protecting enzymes in Parkinson's disease Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus , 1988, Journal of the Neurological Sciences.
[9] J. Cadet,et al. Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: Behavioral and biochemical evidence , 1989, Brain Research.
[10] J. Adams,et al. Oxygen free radicals and Parkinson's disease. , 1991, Free radical biology & medicine.
[11] M. Youdim,et al. Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine. , 1995, European journal of pharmacology.
[12] G. Cohen,et al. The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. , 1974, The Journal of biological chemistry.
[13] G. Nappi,et al. Hydroxyl radical production in the substantia nigra after 6-hydroxydopamine and hypoxia-reoxygenation , 1998, Brain Research.
[14] J. Cadet,et al. Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain , 1992, Brain Research Bulletin.
[15] H. Ischiropoulos,et al. Tyrosine nitration: Localisation, quantification, consequences for protein function and signal transduction , 2001, Free radical research.
[16] A. Lees,et al. A Generalised Increase in Protein Carbonyls in the Brain in Parkinson's but Not Incidental Lewy Body Disease , 1997, Journal of neurochemistry.
[17] S. Fahn,et al. The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it , 1992, Annals of neurology.
[18] M. Zigmond,et al. Estimating Hydroxyl Radical Content in Rat Brain Using Systemic and Intraventricular Salicylate: Impact of Methamphetamine , 1995, Journal of neurochemistry.
[19] W. H. Oertel,et al. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat , 1994, Neuroscience.
[20] S. Tannenbaum,et al. DNA damage in deoxynucleosides and oligonucleotides treated with peroxynitrite. , 1999, Chemical research in toxicology.
[21] M. Guérin,et al. Neurodegenerative disorders: the role of peroxynitrite , 1999, Brain Research Reviews.
[22] C. Marsden,et al. Mitochondrial Complex I Deficiency in Parkinson's Disease , 1990, Lancet.
[23] B. Freeman,et al. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. , 1991, Archives of biochemistry and biophysics.
[24] D. Perl,et al. Protein Nitration in Parkinson's Disease , 1998, Journal of neuropathology and experimental neurology.
[25] B. Ferger,et al. The salicylate hydroxylation assay to measure hydroxyl free radicals induced by local application of glutamate in vivo or induced by the Fenton reaction in vitro. , 2000, Brain research. Brain research protocols.
[26] C. Altar,et al. Time Course of Adaptations in Dopamine Biosynthesis, Metabolism, and Release Following Nigrostriatal Lesions: Implications for Behavioral Recovery from Brain Injury , 1987, Journal of neurochemistry.
[27] K. Jellinger,et al. Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease , 1994, Neuroscience Letters.
[28] B. Halliwell,et al. 6‐Hydroxydopamine increases the hydroxylation and nitration of phenylalanine in vivo: implication of peroxynitrite formation , 2001, Journal of neurochemistry.
[29] B. Halliwell,et al. 6-Hydroxydopamine increases hydroxyl free radical production and DNA damage in rat striatum , 2001, Neuroreport.
[30] J. Poirier,et al. Superoxide Dismutase Expression in Parkinson's Disease , 1994, Annals of the New York Academy of Sciences.
[31] T. Dawson,et al. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[32] P. Jenner,et al. Understanding cell death in parkinson's disease , 1998, Annals of neurology.
[33] C D Marsden,et al. Oxidative DNA Damage in the Parkinsonian Brain: An Apparent Selective Increase in 8‐Hydroxyguanine Levels in Substantia Nigra , 1997, Journal of neurochemistry.
[34] W. Bors,et al. On the nature of biochemically generated hydroxyl radicals. Studies using the bleaching of p-nitrosodimethylaniline as a direct assay method. , 1979, European journal of biochemistry.
[35] D. Loeffler,et al. L‐DOPA Does Not Enhance Hydroxyl Radical Formation in the Nigrostriatal Dopamine System of Rats with a Unilateral 6‐Hydroxydopamine Lesion , 2000, Journal of neurochemistry.
[36] C. Marsden,et al. Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study , 1994, Movement disorders : official journal of the Movement Disorder Society.
[37] M. LaVoie,et al. Peroxynitrite‐ and Nitrite‐Induced Oxidation of Dopamine : Implications for Nitric Oxide in Dopaminergic Cell Loss , 1999, Journal of neurochemistry.
[38] C. Marsden,et al. Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease , 1989, Journal of neurochemistry.
[39] J. Andersen,et al. Oxidative stress in neurodegeneration: cause or consequence? , 2004, Nature Reviews Neuroscience.
[40] P. Jenner,et al. Oxidative stress in Parkinson's disease , 2003, Annals of neurology.